Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil

Ads

You May Also Like

Recro Pharma Reports First Quarter 2017 Financial Results

Reports First Quarter 2017 Revenues of $18.7 Million Recently Announced Successful Top-Line Results from ...